Informe de mercado de terapéutica de ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel en América del Norte: tamaño, compartición y análisis de tendencias - Resumen de la industria y pronóstico hasta 2032

North America Nucleic Acid Therapeutics Sport Food Additives And Skin Care Market

Tamaño del mercado en miles de millones de dólares

Tasa de crecimiento anual compuesta (CAGR) : 7.14 %

USD 5.50 Billion USD 9.54 Billion 2024 2032

Período de pronóstico	2025 –2032
Tamaño del mercado (año base)	USD 5.50 Billion
Tamaño del mercado (año de pronóstico)	USD 9.54 Billion
Tasa de crecimiento anual compuesta (CAGR)	7.14 %
Jugadoras de los principales mercados	Pfizer Inc. Biogen Alnylam Pharmaceuticals Inc. Ionis Pharmaceuticals Inc. AstraZeneca

Segmentación del mercado norteamericano de productos terapéuticos con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel, por producto (productos terapéuticos con ácidos nucleicos, productos para el cuidado de la piel con ácidos nucleicos y aditivos alimentarios deportivos con ácidos nucleicos), origen (ácidos nucleicos naturales y sintéticos), usuario final (consumidores individuales/atención médica domiciliaria y uso profesional/en instalaciones), canal de distribución (licitación directa, venta minorista y otros): tendencias del sector y pronóstico hasta 2032.

Tamaño del mercado de terapias con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel

El mercado de terapias con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel en América del Norte se valoró en USD 5.500 millones en 2024 y se espera que alcance los USD 9.540 millones para 2032.
Durante el período de pronóstico de 2025 a 2032, es probable que el mercado crezca a una CAGR del 7,14 %, impulsado principalmente por la creciente demanda de alimentos funcionales, nutracéuticos e ingredientes bioactivos para el cuidado de la piel.
Este crecimiento está impulsado por factores como la creciente influencia de la medicina personalizada y las soluciones de cuidado de la piel personalizadas, políticas regulatorias favorables y el aumento de las inversiones en I+D en terapias basadas en genes.

Análisis del mercado de terapias con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel

Se proyecta que el mercado de terapias de ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel crecerá significativamente debido a la creciente conciencia de la salud, un mayor enfoque en el bienestar personalizado y los avances en biotecnología e investigación dermatológica.
Los consumidores buscan cada vez más productos que favorezcan la salud celular, el rendimiento físico y el rejuvenecimiento de la piel, lo que impulsa la demanda en estos segmentos.
El mercado está siendo testigo de una rápida innovación, incluidas terapias específicas basadas en genes, productos de nutrición deportiva funcional y formulaciones bioactivas para el cuidado de la piel, que están mejorando la eficacia y ampliando la oferta de productos.
Estas innovaciones están atrayendo tanto a profesionales de la salud como a consumidores que buscan soluciones basadas en resultados y con respaldo científico.

Alcance del informe y segmentación del mercado de terapias con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel

Atributos	Análisis del mercado de terapias con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel
Segmentos cubiertos	Por producto: Ácidos nucleicos terapéuticos, productos para el cuidado de la piel con ácidos nucleicos y aditivos alimentarios deportivos con ácidos nucleicos Por fuente: ácidos nucleicos naturales y ácidos nucleicos sintéticos Por usuario final: consumidores individuales/atención médica domiciliaria y uso profesional/en instalaciones Por canal de distribución: Licitación directa, Ventas minoristas y otros
Países cubiertos	América del norte PIOJO Canadá México
Actores clave del mercado	Pfizer Inc. (EE. UU.) Biogen (EE. UU.) Alnylam Pharmaceuticals, Inc. (EE. UU.) Sarepta Therapeutics, Inc. (EE. UU.) Ionis Pharmaceuticals, Inc. (EE. UU.) AstraZeneca (Reino Unido) Moderna, Inc. (EE. UU.) Novartis AG (Suiza) Spark Therapeutics, Inc. (EE. UU.) Tecnología Biofarmacéutica de Zhejiang Haichang Co., Ltd. (China) Rémy Laure (Francia) NUEVO (EE. UU.) MoonGlow (Ucrania) El químico desnudo (Nueva Zelanda) SKINSHIFT (EE. UU.) Bio Jouvance Paris Consumer (EE. UU.) Instituto de la Piel del ADN (EE. UU.) Juliette Armand (Grecia) Kalichem srl (Italia) NIPPON PAPER INDUSTRIES CO., LTD. (Japón) PostQuam (España) Shopatdna.com (India)
Oportunidades de mercado	Avances en terapias basadas en ARN y ADN, aditivos alimentarios e innovaciones en el cuidado de la piel Expansión a través de alianzas y colaboraciones estratégicas
Conjuntos de información de datos de valor añadido	Además de los conocimientos sobre escenarios de mercado, como valor de mercado, tasa de crecimiento, segmentación, cobertura geográfica y actores principales, los informes de mercado seleccionados por Data Bridge Market Research también incluyen análisis de importación y exportación, descripción general de la capacidad de producción, análisis del consumo de producción, análisis de tendencias de precios, escenario de cambio climático, análisis de la cadena de suministro, análisis de la cadena de valor, descripción general de materias primas/consumibles, criterios de selección de proveedores, análisis PESTLE, análisis de Porter y marco regulatorio.

Tendencias del mercado de terapias con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel

“Convergencia de biotecnología, bienestar personalizado y soluciones de belleza limpia”

Innovaciones como los tratamientos basados en ARNm, las terapias de silenciamiento genético y las fórmulas para el cuidado de la piel personalizadas con ADN están revolucionando la forma en que las personas gestionan la salud, optimizan el rendimiento físico y abordan las afecciones de la piel a nivel molecular.
- Por ejemplo, los productos para el cuidado de la piel basados en ácidos nucleicos se están adaptando a perfiles genéticos individuales, lo que permite regímenes personalizados que abordan problemas específicos como el envejecimiento, la pigmentación y la inflamación.
En el ámbito de la nutrición deportiva, los aditivos de etiqueta limpia y con respaldo científico están ganando terreno, impulsados por la demanda de una mejor recuperación muscular, rendimiento cognitivo y reparación celular, a menudo respaldados por datos genómicos.

Dinámica del mercado de terapias con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel

Conductor

Creciente demanda de alimentos funcionales, nutracéuticos e ingredientes bioactivos para el cuidado de la piel.

A medida que los consumidores se vuelven más conscientes de la salud, buscan cada vez más productos que ofrezcan más que una nutrición básica: productos que puedan mejorar la función metabólica, mejorar la recuperación y apoyar la salud inmunológica.
En el sector alimentario, los alimentos funcionales que aportan beneficios específicos para la salud, como una mejor digestión, una mejor función cognitiva y una mejor recuperación muscular, se están convirtiendo en una tendencia importante.
Los alimentos funcionales basados en ARN y ADN son particularmente notables, ya que los avances en estos campos permiten enfoques nutricionales más personalizados. Estos ingredientes bioactivos no solo mejoran la salud general, sino que también respaldan intervenciones de salud más específicas basadas en predisposiciones genéticas.
- Por ejemplo, en enero de 2021, un artículo publicado por la Biblioteca Nacional de Medicina destacó el creciente uso de compuestos bioactivos en alimentos y productos para el cuidado de la piel, destacando su potencial para mejorar la salud metabólica, la inmunidad y la regeneración cutánea. Subraya la creciente importancia de los ingredientes funcionales para abordar los problemas de salud relacionados con la edad y optimizar el bienestar general.
- Por ejemplo, en noviembre de 2021, Elsevier BV publicó un artículo que analiza los avances en nutracéuticos, centrándose particularmente en los ingredientes basados en ARN y ADN que mejoran las funciones metabólicas y apoyan el microbioma intestinal.
Estos avances están cambiando las preferencias de los consumidores hacia productos que ofrecen más que solo nutrición básica, atendiendo la demanda de soluciones de salud personalizadas.
La creciente demanda de alimentos funcionales, nutracéuticos y productos bioactivos para el cuidado de la piel impulsa la innovación hacia soluciones personalizadas con respaldo científico. Las tecnologías basadas en ARN y ADN permiten productos más específicos que mejoran el metabolismo, la recuperación muscular y la salud de la piel.

Oportunidad

Avances en terapias basadas en ARN y ADN, aditivos alimentarios e innovaciones en el cuidado de la piel.

Los avances en las tecnologías basadas en ARN y ADN están abriendo nuevas fronteras. En el ámbito terapéutico, las vacunas de ARNm y las herramientas de edición genética como CRISPR han revolucionado la medicina, ofreciendo posibles curas para trastornos genéticos, cánceres e infecciones virales.
En el cuidado de la piel, las fórmulas basadas en ADN y ARN están transformando los tratamientos antienvejecimiento y reparadores de la piel. El ADN de origen marino, los péptidos de ARN y los exosomas se están incorporando a productos de alta gama para el cuidado de la piel para promover la renovación celular, reparar la piel dañada y combatir los factores de estrés ambiental.
El auge de los diagnósticos de cuidado de la piel basados en genes fortalece aún más la demanda, lo que permite regímenes de cuidado de la piel personalizados y adaptados al perfil genético de cada individuo.
Estos avances se alinean con las tendencias cosméticas impulsadas por la biotecnología y la belleza limpia, mejorando las oportunidades para los cosmecéuticos premium.

Por ejemplo,

En enero de 2023, según Springer Nature Limited, la tecnología de edición genética CRISPR/Cas9 está avanzando en el tratamiento de enfermedades genéticas al corregir mutaciones dañinas o desactivar genes que causan enfermedades.

Destaca las mejoras en los métodos de edición genética, los sistemas de administración y los enfoques de tratamiento, enfatizando la importancia de elegir las técnicas adecuadas para diferentes enfermedades y garantizar una aplicación segura y efectiva.
En agosto de 2023, según Elsevier BV, el estudio destaca avances en terapias basadas en ARN y ADN, en particular la edición genómica CRISPR/Cas9, que permite modificaciones precisas del ADN para el tratamiento de trastornos genéticos. Los avances en terapias basadas en ARNm mejoran aún más el tratamiento de enfermedades, mejorando la eficacia y los resultados de los pacientes en terapia génica y medicina regenerativa.

La integración de innovaciones basadas en ARN y ADN en las áreas de terapéutica, alimentación y cuidado de la piel está transformando las industrias con soluciones personalizadas y de alta eficacia. A medida que avanza la investigación, una mayor accesibilidad, asequibilidad y apoyo regulatorio acelerarán su adopción, posicionando a los ácidos nucleicos como impulsores clave de los futuros mercados de la salud, la nutrición y la belleza.

Restricción/Desafío

Baja conciencia pública y tasas de adopción lentas

A pesar de los avances en terapias basadas en ARN y ADN, aditivos alimentarios funcionales y cuidado de la piel basado en genes, muchos consumidores siguen desinformados o son escépticos sobre estas innovaciones.
Esta falta de conocimiento retrasa el crecimiento del mercado y crea barreras para la aceptación, lo que dificulta que las empresas ganen la confianza generalizada de los consumidores.
En la terapéutica de ácidos nucleicos, la complejidad de los tratamientos basados en ARN y ADN y las preocupaciones sobre la edición genética y la tecnología del ARNm han generado dudas entre los pacientes y los proveedores de atención médica.
Las ideas erróneas sobre la seguridad, los efectos a largo plazo y las implicaciones éticas de los fármacos basados en ácidos nucleicos dificultan aún más su adopción. Las aprobaciones regulatorias y la validación clínica son esenciales, pero sin campañas educativas eficaces, estas innovaciones tienen dificultades para lograr una aceptación generalizada.
En el mercado de aditivos alimentarios para deportistas, los suplementos a base de ácidos nucleicos aún no se han generalizado debido a la falta de información del consumidor sobre sus beneficios. Muchas personas desconocen cómo los ácidos nucleicos contribuyen a la recuperación muscular, el metabolismo energético y el rendimiento deportivo general.
Sin estrategias claras de marketing y comunicación científica, estos productos quedan en nichos, lo que limita su penetración en el mercado.

Por ejemplo,

Por ejemplo, en junio de 2021, según Elsevier BV, se destacó la importancia de educar al consumidor sobre los beneficios para la salud y la seguridad de los productos probióticos. Se destaca que una mayor concienciación puede conducir a una mejor aceptación y a decisiones informadas entre los consumidores.
En julio de 2023, se publicó un artículo titulado Una descripción general de los suplementos dietéticos en América del Norte: regulación, tendencias del mercado, uso durante la pandemia de COVID-19 y efectos sobre la salud. En los últimos 20 años, el uso de suplementos dietéticos (SD) ha crecido en América del Norte, y la demanda ha aumentado durante la COVID-19 debido a los temores a las vacunas y las afirmaciones sobre el fortalecimiento del sistema inmunológico.
A pesar de la evidencia limitada, las ventas aumentaron, lo que generó inquietud sobre la eficacia y la seguridad. La escasa concienciación pública subraya la necesidad de claridad regulatoria y educación del consumidor sobre los beneficios y riesgos del DS.

La baja concienciación pública y las lentas tasas de adopción dificultan significativamente la expansión del mercado en estos sectores. Las empresas deben invertir en educación del consumidor, comunicación transparente y marketing estratégico para generar confianza y acelerar la aceptación.
La colaboración con profesionales de la salud, personas influyentes y organismos reguladores puede ayudar a generar conciencia y mejorar la adopción en el mercado.

Ámbito del mercado de la terapia con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel

El mercado está segmentado según el tipo de producto, la fuente, el usuario final y el canal de distribución.

Segmentación	Subsegmentación
Por producto	Terapéutica de ácidos nucleicos Terapia de ácidos nucleicos, por categoría Antisentido Antisentido, por moléculas Estoy cansado. Calentamiento Golodirsen Inotersen Volanesorsen Otros Antisentido, por drogas Spinraza Exondys 51 Tegsedi Otros Interferencia de ARN Interferencia de ARN, por moléculas Vutrisirán Givosiran Participativo Lubricar Interferencia del ARN por fármacos Buitres Givlaari Onpattro Oxlumo Interferencia de ARN, por tipo Virus de ARN bicatenario (ARNdc) ARN de interferencia pequeño (ARNip) microARN (miARN) Oligonucleótidos CPG Oligonucleótidos CPG, por tipo Adyuvantes CpG en vacunas Oligonucleótidos CpG tipo B Aptámeros Otros Terapia de ácidos nucleicos, por estructura ARN monocatenario ADN de doble cadena ADN monocatenario ARN/ADN monocatenario Terapia de ácidos nucleicos, por tipo de fármaco Medicamentos comercializados/aprobados Medicamentos comercializados/aprobados, por tipo Fármacos de ácidos nucleicos pequeños Vacunas de ARNm Otros Medicamentos en desarrollo Terapia de ácidos nucleicos, por aplicación Trastornos genéticos Trastornos neurológicos enfermedades infecciosas enfermedades autoinmunes Otros Terapia de ácidos nucleicos, por vía de administración Intratecal Subcutáneo Intravenoso Otros Productos para el cuidado de la piel con ácidos nucleicos Productos para el cuidado de la piel con ácidos nucleicos, por tipo Cuidado de la piel basado en el ADN Cuidado de la piel basado en el ADN, por tipo Sueros reparadores de ADN Sueros reparadores de ADN, por tipo Sueros de ADN antienvejecimiento Sueros hidratantes de ADN Sueros potenciadores del colágeno basados en ADN Humectantes con infusión de ADN Hidratantes con ADN, por tipo Cremas de día Cremas de noche Cremas de hidratación profunda Otros Protectores solares a base de ADN Protectores solares basados en ADN, por tipo Protección UV de amplio espectro Protectores solares de ADN antifotoenvejecimiento Mascarillas faciales basadas en ADN Mascarillas faciales basadas en ADN, por tipo Mascarillas de lámina Mascarillas de arcilla Mascarillas de gel Otros Cremas para ojos con infusión de ADN Cremas para ojos con ADN, por tipo Cremas antiojeras Cremas para reducir líneas finas y arrugas Cremas para reducir la hinchazón Otros Cuidado de la piel basado en ARN Cuidado de la piel basado en ARN, por tipo Cremas con infusión de ARN Tratamientos antienvejecimiento basados en ARN Cremas con infusión de ARN, por tipo Cremas antienvejecimiento con ARN Cremas reparadoras de barrera Cremas hidratantes intensivas Otros Tratamientos antienvejecimiento basados en ARN, por tipo Fórmulas para reducir las arrugas Tratamientos de rejuvenecimiento de la piel Otros Productos para el cuidado de la piel con terapia genética Productos para el cuidado de la piel con terapia genética, por tipo Cuidado de la piel personalizado con modificaciones de ADN/ARN Tratamientos epigenéticos para el cuidado de la piel Otros Otros Productos para el cuidado de la piel con ácidos nucleicos, según el tipo de piel Piel seca Piel normal Piel grasa Piel mixta Piel sensible Otros Productos para el cuidado de la piel con ácidos nucleicos, por envase Botellas Botellas, por tipo Botellas exprimibles Botellas con bomba Botellas de spray Otros Tubos Tubos, por tipo Tapas giratorias Tapas abatibles Tubos de compresión sin aire Otros Frascos goteros Frascos goteros, por tipo Pipetas goteras goteros con pulsador Paso Frascos, por tipo Tapas de rosca Tapas abatibles Frascos con espátula incluida Otros Ampollas Ampollas, por tipo Ampollas de un solo uso Ampollas multidosis Sobres y bolsas Sobres y bolsas, por tipo Sobres desprendibles Bolsas resellables Otros Productos para el cuidado de la piel con ácidos nucleicos, por tamaño de envase Envase mediano (31 ml – 75 ml) Envase pequeño (1 ml – 30 ml) Envase de gran tamaño (76 ml – 200 ml) Envase extra grande (más de 200 ml) Productos para el cuidado de la piel con ácidos nucleicos, por rango de precio Masa De primera calidad Lujo Productos para el cuidado de la piel con ácidos nucleicos, por aplicación Hidratación y humectación Hidratación y humectación, por tipo Hidratación profunda CON ácidos nucleicos Hidratación profunda con ácidos nucleicos, por tipo Cremas bloqueadoras de agua a base de ADN Potenciadores de hidratación potenciados por ARN Sueros de hidratación de larga duración Sueros de hidratación de larga duración, por tipo Sueros de ARN con hidratación de 24 horas Tratamientos hidratantes potenciados por el ADN Fortalecimiento de la barrera cutánea Cremas de ceramidas con infusión de ácido nucleico Potenciadores epigenéticos de la resiliencia de la piel Regeneración y reparación de la piel Tratamientos postoperatorios y de curación intensiva Cremas cicatrizantes a base de ADN Sueros reparadores de cicatrices con infusión de ARN Formulaciones para la recuperación de la barrera cutánea Tratamientos de renovación celular Sueros renovadores de la piel que estimulan el ADN Mascarillas reparadoras de la piel enzimáticas a base de ARN Reparación de daños en el ADN Cremas para revertir el daño del ADN inducido por los rayos UV Sueros reparadores epigenéticos Otros Protección UV y reparación del daño solar Protectores solares a base de ADN Protección UVA/UVB de amplio espectro Fórmulas de defensa contra el fotoenvejecimiento Tratamientos reparadores del ADN después del sol Mascarillas post-exposición solar con ADN Geles recuperadores de quemaduras solares a base de ARN Protección contra la luz azul y la contaminación Cremas de defensa digital con ADN Sueros de protección ambiental basados en ARN Tratamiento del acné y las cicatrices Sueros para el control del acné basados en ADN Sueros de ácidos nucleicos antibacterianos Tratamientos con ARN seborreguladores Cremas para atenuar cicatrices con ARN Correctores de marcas post-acné Sueros de regeneración tisular epigenética Tratamientos hormonales para el acné Cuidado de la piel con equilibrio hormonal basado en el ADN Geles antiinflamatorios con infusión de ARN Control de grasa y reducción de poros Cremas equilibrantes de grasa con ADN Tónicos reafirmantes de poros a base de ARN Tratamiento de hiperpigmentación y manchas oscuras Correctores de manchas oscuras Tratamientos de atenuación de manchas basados en ADN Reductores de decoloración potenciados por ARN Corrección del tono desigual de la piel Mascarillas iluminadoras de piel a base de ADN Soluciones para un tono de piel uniforme y específico para los genes Sueros inhibidores de melanina Inhibidores de la tirosinasa basados en ADN Sueros iluminadores potenciados con ARN Tratamientos para la hiperpigmentación postinflamatoria (HPI) Correctores de marcas de acné con infusión de ácido nucleico Cremas antienrojecimiento a base de ARN Antienvejecimiento y reducción de arrugas Fórmulas que estimulan el colágeno Sueros de colágeno con infusión de ADN Potenciadores de péptidos basados en ARN Mascarillas de colágeno que estimulan los genes Otros Reafirmación y mejora de la elasticidad de la piel Sueros reafirmantes de la piel a base de ADN Cremas que mejoran la elasticidad con ARN Mascarillas faciales reafirmantes con ácido nucleico Otros Tratamiento de líneas finas Correctores de la línea de la frente Cremas para reducir las patas de gallo Sueros para las arrugas debajo de los ojos Tratamiento del pliegue nasolabial Otros Reparación de arrugas profundas Alternativas al retinol basadas en ADN Sueros epigenéticos antiarrugas Otros Cuidado de la piel sensible y reducción de la inflamación Fórmulas calmantes y antienrojecimiento Tratamientos para la rosácea basados en ARN Mascarillas calmantes con infusión de ADN Cuidado de la piel hipoalergénico basado en ADN Cremas de ARN para pieles sensibles Sueros de ADN sin fragancia Tratamientos antiinflamatorios con ácidos nucleicos Sueros reductores de citocinas potenciados con ADN Geles reductores de irritación basados en ARN Aditivos alimentarios deportivos con ácidos nucleicos Aditivos alimentarios deportivos de ácidos nucleicos, por aplicación Suplementos deportivos Polvo Cápsulas Otros Comida deportiva
Por fuente	Ácidos nucleicos naturales A base de plantas Derivado del mar Otros Ácidos nucleicos sintéticos
Por el usuario final	Consumidores individuales/Atención médica domiciliaria Mujer Hombres Unisexo Uso profesional/de instalaciones Clínicas de Dermatología Salones de belleza y spas Clínicas especializadas Hospital Otros
Por canal de distribución	Licitación directa Ventas minoristas Basado en la tienda Supermercados/Hipermercados Tiendas de belleza especializadas Farmacias y droguerías Clínicas de dermatología y spas médicos Venta minorista de viajes Otros No basado en tienda Sitios web de comercio electrónico/farmacias Sitios web propiedad de la empresa Otros

Análisis regional del mercado de terapias con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel

EE. UU. es el país dominante en el mercado de terapias con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel.

Estados Unidos lidera el mercado, impulsado por un sector de biotecnología bien establecido, un alto gasto de los consumidores en productos de bienestar y una fuerte presencia de empresas líderes farmacéuticas, nutracéuticas y de cuidado de la piel.
Estados Unidos tiene una importante participación en el mercado debido a la rápida adopción de terapias basadas en ácidos nucleicos, la creciente demanda de aditivos alimentarios funcionales y que mejoran el rendimiento y el creciente interés en soluciones para el cuidado de la piel con respaldo científico.
Las sólidas inversiones en I+D, especialmente en terapia genética y tecnología de ARNm, junto con marcos regulatorios favorables y acceso a capacidades de fabricación avanzadas, contribuyen a un dominio sostenido del mercado.
Además, la creciente conciencia sobre la salud personalizada, la creciente preferencia por productos de etiqueta limpia y bioactivos y la disponibilidad de marcas premium de cuidado de la piel están impulsando la expansión del mercado en toda la región.

“Se proyecta que EE. UU. registre la tasa de crecimiento más alta”

Se espera que la región de EE. UU. sea testigo del crecimiento más rápido, impulsado por el aumento del gasto en atención médica, la creciente demanda de bienestar personalizado y las industrias de biotecnología y cosméticos en rápido crecimiento.
Países como Estados Unidos se están convirtiendo en un motor clave de crecimiento debido a sus grandes poblaciones, las crecientes preocupaciones de salud relacionadas con el estilo de vida y un enfoque creciente en la atención preventiva y el bienestar estético.
Estados Unidos, con su sector biofarmacéutico avanzado y su industria del cuidado de la piel impulsada por la innovación, continúa liderando la adopción de tecnologías basadas en ácidos nucleicos y productos de belleza basados en la ciencia.
La expansión de las plataformas de comercio electrónico, el creciente acceso de los consumidores a productos premium y la localización de marcas internacionales aceleran aún más el crecimiento del mercado en la región.

Cuota de mercado de productos terapéuticos con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel

El panorama competitivo del mercado proporciona detalles por competidor. Se incluye información general de la empresa, sus estados financieros, ingresos generados, potencial de mercado, inversión en investigación y desarrollo, nuevas iniciativas de mercado, presencia en Norteamérica, plantas de producción, capacidad de producción, fortalezas y debilidades de la empresa, lanzamiento de productos, alcance y variedad de productos, y dominio de las aplicaciones. Los datos anteriores se refieren únicamente al enfoque de mercado de las empresas.

Los principales líderes del mercado que operan en el mercado son:

Pfizer Inc. (EE. UU.)
Biogen (EE. UU.)
Alnylam Pharmaceuticals, Inc. (EE. UU.)
Ionis Pharmaceuticals (EE. UU.)
Novartis AG (Suiza)
Spark Therapeutics, Inc. (EE. UU.)
Tecnología Biofarmacéutica de Zhejiang Haichang Co., Ltd. (China)
Moderna, Inc. (EE. UU.)
AstraZeneca (Reino Unido/Suecia)
Sarepta Therapeutics, Inc. (EE. UU.)
Rémy Laure (Francia)
NUEVO (EE. UU.)
MoonGlow (EE. UU.)
El químico desnudo (Nueva Zelanda)
SKINSHIFT (EE. UU.)
Rémy Laure (Francia)
NUEVO (EE. UU.)
MoonGlow (Ucrania)
El químico desnudo (Nueva Zelanda)
SKINSHIFT (EE. UU.)
Bio Jouvance Paris Consumer (EE. UU.)
Instituto de la Piel del ADN (EE. UU.)
Juliette Armand (Grecia)
Kalichem srl (Italia)
NIPPON PAPER INDUSTRIES CO., LTD. (Japón)
PostQuam (España)
Shopatdna.com (India)

Últimos avances en el mercado de ácidos nucleicos terapéuticos, aditivos alimentarios deportivos y cuidado de la piel.

En febrero de 2025, Biogen y Stoke Therapeutics se asociaron para desarrollar y comercializar zorevunersén, una posible terapia modificadora de la enfermedad, primera en su clase, para el síndrome de Dravet. Este oligonucleótido antisentido en investigación se dirige al gen SCN1A para reducir las convulsiones y mejorar la cognición. Un estudio de fase 3 comienza en 2025, y se prevé la presentación de solicitudes regulatorias en 2027. Stoke conserva los derechos en EE. UU., mientras que Biogen se encarga de la comercialización en Norteamérica.
En marzo de 2025, Biogen establecerá su nueva sede en Norteamérica en Kendall Common, Cambridge, Massachusetts, como parte de una consolidación inmobiliaria plurianual. Las instalaciones de vanguardia, cuya inauguración está prevista para 2028, fomentarán la colaboración, la innovación y la sostenibilidad, a la vez que albergarán a los equipos de investigación, desarrollo y comercial de Biogen, junto con el Biogen CoLab para la formación en ciencias de la vida.
En marzo de 2025, Ionis Pharmaceuticals, Inc. anunció la aprobación de Wainzua (Eplontersen) por parte de la Agencia Europea de Medicamentos (EMA) para el tratamiento de la amiloidosis hereditaria por transtiretina (hATTR). Esta terapia antisentido actúa sobre la causa subyacente de la enfermedad y ofrece una nueva opción terapéutica para los pacientes que padecen esta rara y potencialmente mortal afección.
En febrero de 2024, Pfizer Inc. y el Centro Médico UT Southwestern se asociaron para desarrollar tecnologías avanzadas de administración de ARN para medicina genética. Esta colaboración integra la experiencia de UTSW en sistemas de administración de nanopartículas lipídicas (LNP) con la innovación en ARN de Pfizer para optimizar las terapias basadas en ARN. La investigación busca expandir las aplicaciones de edición genética, mejorar la administración dirigida y acelerar el desarrollo de medicamentos genéticos de nueva generación.
En enero de 2022, Pfizer Inc. se asoció con Acuitas Therapeutics para expandir la tecnología de administración de nanopartículas lipídicas (LNP) para vacunas y terapias basadas en ARNm. Este acuerdo permite a Pfizer licenciar la tecnología LNP de Acuitas para hasta 10 dianas, lo que fortalece su estrategia de ARNm. La colaboración impulsa el desarrollo de vacunas y permite el desarrollo de medicamentos genéticos de nueva generación, basándose en el éxito de COMIRNATY, la vacuna de Pfizer-BioNTech contra la COVID-19.

SKU-73896

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

Click on image to enlarge

Panel de análisis de datos interactivo
Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
Acceso de analista de investigación para personalización y consultas
Análisis de la competencia con panel interactivo
Últimas noticias, actualizaciones y análisis de tendencias
Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia

Solicitud de demostración

Tabla de contenido

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 DBMR VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTER’S FIVE FORCES

4.2.1 THREAT OF NEW ENTRANTS

4.2.2 BARGAINING POWER OF BUYERS

4.2.3 BARGAINING POWER OF SUPPLIERS

4.2.4 THREAT OF SUBSTITUTES

4.2.5 COMPETITIVE RIVALRY

4.3 IMPORT EXPORT SCENARIO

4.4 PRICING ANALYSIS

4.5 PRODUCTION CAPACITY FOR TOP MANUFACTURERS

4.6 BRAND OUTLOOK

4.6.1 BRAND COMPARATIVE ANALYSIS OF NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES AND SKIN CARE MARKET

4.6.2 PRODUCT VS BRAND OVERVIEW

4.6.2.1 PRODUCT OVERVIEW

4.6.2.2 BRAND OVERVIEW

4.7 CONSUMER BUYING BEHAVIOUR FOR THE NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES MARKET AND NORTH AMERICA NUCLEIC ACID SKIN CARE MARKET

4.7.1 AWARENESS AND EDUCATION

4.7.2 HEALTH AND PERFORMANCE-ORIENTED BUYERS

4.7.3 PREFERENCE FOR NATURAL AND SCIENTIFIC FORMULATIONS

4.7.4 PRICE SENSITIVITY AND WILLINGNESS TO PAY FOR QUALITY

4.7.5 ROLE OF BRAND TRUST AND REVIEWS

4.7.6 DIGITAL-FIRST SHOPPING EXPERIENCE

4.7.7 REGULATORY AND SAFETY CONCERNS

4.7.8 SUSTAINABILITY AND ETHICAL CONSIDERATIONS

4.8 FACTORS AFFECTING BUYING DECISION FOR NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES MARKET AND NORTH AMERICA NUCLEIC ACID SKIN CARE MARKET

4.8.1 SCIENTIFIC VALIDATION AND EFFICACY

4.8.2 PRICE AND PERCEIVED VALUE

4.8.3 BRAND REPUTATION AND TRUST

4.8.4 PERSONAL HEALTH AND SKIN CONCERNS

4.8.5 DIGITAL INFLUENCE AND E-COMMERCE ACCESSIBILITY

4.8.6 REGULATORY APPROVALS AND SAFETY ASSURANCE

4.8.7 ETHICAL AND SUSTAINABILITY CONSIDERATIONS

4.8.8 AVAILABILITY AND CONVENIENCE

4.9 IMPACT OF ECONOMIC SLOWDOWN ON NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES MARKET AND NORTH AMERICA NUCLEIC ACID SKIN CARE MARKET

4.9.1 IMPACT ON PRICE

4.9.2 IMPACT ON SUPPLY CHAIN

4.9.3 IMPACT ON SHIPMENT

4.9.4 IMPACT ON DEMAND

4.9.5 IMPACT ON STRATEGIC DECISIONS

4.1 PRODUCT ADOPTION SCENARIO FOR NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES MARKET AND NORTH AMERICA NUCLEIC ACID SKIN CARE MARKET

4.10.1 AWARENESS AND MARKET PENETRATION

4.10.2 CONSUMER SEGMENTATION AND ADOPTION TRENDS

4.10.3 INFLUENCE OF SCIENTIFIC RESEARCH AND REGULATORY APPROVALS

4.10.4 PRICING, ACCESSIBILITY, AND DISTRIBUTION CHANNELS

4.11 RAW MATERIAL SOURCING ANALYSIS

4.11.1 SOURCES OF NUCLEIC ACIDS FOR FOOD ADDITIVES AND SKINCARE

4.11.2 SUPPLY CHAIN CHALLENGES IN RAW MATERIAL PROCUREMENT

4.11.3 QUALITY CONTROL AND REGULATORY COMPLIANCE

4.11.4 COST IMPLICATIONS OF RAW MATERIAL SOURCING

4.11.5 SUSTAINABILITY AND ETHICAL SOURCING

4.12 SUPPLY CHAIN ANALYSIS FOR NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES MARKET AND NORTH AMERICA NUCLEIC ACID SKIN CARE MARKETS

4.13 OVERVIEW

4.13.1 LOGISTIC COST SCENARIO

4.13.2 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS

4.14 PATENT ANALYSIS

4.15 PIPELINE

4.16 MERGERS & ACQUISITIONS

4.17 INDUSTRY INSIGHTS

5 PIPELINE ANALYSIS:

6 EPIDEMIOLOGY

6.1 INCIDENCE BY GENDER

6.2 TREATMENT RATES

6.3 MORTALITY RATES

6.4 DRUG ADHERENCE AND THERAPY SWITCH MODELS

6.5 PATIENT TREATMENT SUCCESS RATES

7 REGULATORY COVERAGE

8 MARKET OVERVIEW

8.1 DRIVERS

8.1.1 GROWING DEMAND FOR FUNCTIONAL FOODS, NUTRACEUTICALS, AND BIOACTIVE SKINCARE INGREDIENTS

8.1.2 RISING INFLUENCE OF PERSONALIZED MEDICINE AND CUSTOMIZED SKINCARE SOLUTIONS

8.1.3 FAVORABLE REGULATORY POLICIES AND RISING R&D INVESTMENTS IN GENE-BASED THERAPIES

8.1.4 INCREASING PREVALENCE OF CHRONIC DISEASES AND AN AGING NORTH AMERICA POPULATION

8.2 RESTRAINTS

8.2.1 INCREASING TREATMENT COSTS DUE TO HIGH PRODUCTION EXPENSES IN GENE-BASED THERAPIES

8.2.2 POTENTIAL RISKS AND SIDE EFFECTS OF GENE-BASED TREATMENTS

8.3 OPPORTUNITIES

8.3.1 BREAKTHROUGHS IN RNA AND DNA-BASED THERAPIES, FOOD ADDITIVES, AND SKINCARE INNOVATIONS

8.3.2 EXPANSION THROUGH STRATEGIC PARTNERSHIPS AND COLLABORATIONS

8.3.3 TECHNOLOGICAL ADVANCEMENTS IN DRUG DELIVERY SYSTEMS

8.4 CHALLENGES

8.4.1 LOW PUBLIC AWARENESS AND SLOW ADOPTION RATES

8.4.2 INTELLECTUAL PROPERTY COMPLEXITIES AND PATENT-RELATED HURDLES

9 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PRODUCT

9.1 OVERVIEW

9.2 NUCLEIC ACID THERAPEUTICS

9.2.1 BY CATEGORY

9.2.1.1 ANTISENSE

9.2.1.1.1 BY MOLECULES

9.2.1.1.1.1 NUSINERSEN

9.2.1.1.1.2 ETEPLIRSEN

9.2.1.1.1.3 GOLODIRSEN

9.2.1.1.1.4 INOTERSEN

9.2.1.1.1.5 VOLANESORSEN

9.2.1.1.1.6 OTHERS

9.2.1.1.2 BY DRUGS

9.2.1.1.2.1 SPINRAZA

9.2.1.1.2.2 EXONDYS 51

9.2.1.1.2.3 TEGSEDI

9.2.1.1.2.4 OTHERS

9.2.2 RNA INTERFERENCE

9.2.2.1 BY MOLECULES

9.2.2.1.1 VUTRISIRAN

9.2.2.1.2 GIVOSIRAN

9.2.2.1.3 PATISIRAN

9.2.2.1.4 LUMASIRAN

9.2.2.2 BY DRUGS

9.2.2.2.1 AMVUTRA

9.2.2.2.2 GIVLAARI

9.2.2.2.3 ONPATTRO

9.2.2.2.4 OXLUMO

9.2.2.3 BY TYPE

9.2.2.3.1 DOUBLE-STRANDED RNA VIRUSES (DSRNA)

9.2.2.3.2 SMALL INTERFERING RNA (SIRNA)

9.2.2.3.3 MICRORNAS (MIRNA)

9.2.3 CPG OLIGONUCLEOTIDES

9.2.3.1 BY TYPE

9.2.3.1.1 CPG ADJUVANTS IN VACCINES

9.2.3.1.2 TYPE B CPG OLIGONUCLEOTIDES

9.2.4 APTAMERS

9.2.5 OTHERS

9.2.6 BY STRUCTURE

9.2.6.1 SINGLE-STRANDED RNA

9.2.6.2 DOUBLE-STRANDED DNA

9.2.6.3 SINGLE-STRANDED DNA

9.2.6.4 SINGLE-STRANDED RNA/DNA

9.2.7 BY DRUG TYPE

9.2.7.1 MARKETED/ APPROVED DRUGS

9.2.7.1.1 SMALL NUCLEIC ACID DRUGS

9.2.7.1.2 MRNA VACCINES

9.2.7.1.3 OTHERS

9.2.7.2 PIPELINE DRUGS

9.2.8 BY APPLICATION

9.2.8.1 GENETIC DISORDERS

9.2.8.2 NEUROLOGICAL DISORDERS

9.2.8.3 INFECTIOUS DISEASES

9.2.8.4 AUTOIMMUNE DISEASES

9.2.8.5 OTHERS

9.2.9 BY ROUTE OF ADMINISTRATION

9.2.9.1 INTRATHECAL

9.2.9.2 SUBCUTANEOUS

9.2.9.3 INTRAVENOUS

9.2.9.4 OTHERS

9.3 NUCLEIC ACID SKIN CARE PRODUCTS

9.3.1 DNA-BASED SKIN CARE

9.3.1.1 DNA REPAIR SERUMS

9.3.1.1.1 ANTI-AGING DNA SERUMS

9.3.1.1.2 HYDRATING DNA SERUMS

9.3.1.1.3 DNA-BASED COLLAGEN-BOOSTING SERUMS

9.3.2 DNA-INFUSED MOISTURIZERS

9.3.2.1.1 DAY CREAMS

9.3.2.1.2 NIGHT CREAMS

9.3.2.1.3 DEEP HYDRATION CREAMS

9.3.2.1.4 OTHERS

9.3.2.2 DNA-BASED SUNSCREENS

9.3.2.2.1 BROAD-SPECTRUM UV PROTECTION

9.3.2.2.2 ANTI-PHOTOAGING DNA SUNSCREENS

9.3.2.3 DNA-BASED FACE MASKS

9.3.2.3.1 SHEET MASKS

9.3.2.3.2 CLAY MASKS

9.3.2.3.3 GEL MASKS

9.3.2.3.4 OTHERS

9.3.2.4 DNA-INFUSED EYE CREAMS

9.3.2.4.1 ANTI-DARK CIRCLE CREAMS

9.3.2.4.2 FINE LINE & WRINKLE REDUCTION CREAMS

9.3.2.4.3 PUFFINESS REDUCTION CREAMS

9.3.2.4.4 OTHERS

9.4 RNA-BASED SKIN CARE

9.4.1 RNA-INFUSED CREAMS

9.4.1.1 ANTI-AGING RNA CREAMS

9.4.1.2 BARRIER REPAIR CREAMS

9.4.1.3 INTENSIVE MOISTURE CREAMS

9.4.1.4 OTHERS

9.4.2 RNA-BASED ANTI-AGING TREATMENTS

9.4.2.1 WRINKLE REDUCTION FORMULATIONS

9.4.2.2 SKIN REJUVENATION TREATMENTS

9.4.2.3 OTHERS

9.4.3 GENE THERAPY-INFUSED SKIN CARE PRODUCTS

9.4.3.1 PERSONALIZED SKINCARE WITH DNA/RNA MODIFICATIONS

9.4.3.2 EPIGENETIC SKIN CARE TREATMENTS

9.4.3.3 OTHERS

9.4.4 BY SKIN TYPE

9.4.4.1 DRY SKIN

9.4.4.2 NORMAL SKIN

9.4.4.3 OILY SKIN

9.4.4.4 COMBINATION SKIN

9.4.4.5 SENSITIVE SKIN

9.4.4.6 OTHERS

9.4.5 BY PACKAGING

9.4.5.1 BOTTLES

9.4.5.1.1 SQUEEZE BOTTLES

9.4.5.1.2 PUMP BOTTLES

9.4.5.1.3 SPRAY BOTTLES

9.4.5.1.4 OTHERS

9.4.5.2 TUBES

9.4.5.2.1 TWIST CAPS

9.4.5.2.2 FLIP-TOP CAPS

9.4.5.2.3 AIRLESS SQUEEZE TUBES

9.4.5.2.4 OTHERS

9.4.5.3 DROPPER BOTTLES

9.4.5.3.1 PIPETTE DROPPERS

9.4.5.3.2 PUSH-BUTTON DROPPERS

9.4.5.4 JARS

9.4.5.4.1 SCREW-TOP LIDS

9.4.5.4.2 FLIP-TOP LIDS

9.4.5.4.3 SPATULA-INCLUDED JARS

9.4.5.4.4 OTHERS

9.4.5.5 AMPOULES

9.4.5.5.1 SINGLE-USE AMPOULES

9.4.5.5.2 MULTI-DOSE AMPOULES

9.4.5.6 SACHETS AND POUCHES

9.4.5.6.1 TEAR-OFF SACHETS

9.4.5.6.2 RESEALABLE POUCHES

9.4.5.7 OTHERS

9.4.6 BY PACKAGING SIZE

9.4.6.1 MEDIUM-SIZED PACKAGING (31 ML – 75 ML)

9.4.6.2 SMALL-SIZED PACKAGING (1 ML – 30 ML)

9.4.6.3 LARGE-SIZED PACKAGING (76 ML – 200 ML)

9.4.6.4 EXTRA-LARGE PACKAGING (ABOVE 200 ML)

9.4.7 BY PRICE RANGE

9.4.7.1 MASS

9.4.7.2 PREMIUM

9.4.7.3 LUXURY

9.4.8 BY APPLICATION

9.4.8.1 MOISTURIZATION & HYDRATION

9.4.8.1.1 DEEP HYDRATION WITH NUCLEIC ACIDS

9.4.8.1.1.1 DNA-BASED WATER-LOCK CREAMS

9.4.8.1.1.2 RNA-POWERED HYDRATION BOOSTERS

9.4.8.1.2 LONG-LASTING HYDRATION SERUMS

9.4.8.1.2.1 24-HOUR HYDRATION RNA SERUMS

9.4.8.1.2.2 DNA-POWERED MOISTURE-LOCKING TREATMENTS

9.4.8.1.3 SKIN BARRIER STRENGTHENING

9.4.8.1.3.1 NUCLEIC ACID-INFUSED CERAMIDE CREAMS

9.4.8.1.3.2 EPIGENETIC SKIN RESILIENCE ENHANCERS

9.4.8.2 SKIN REGENERATION & REPAIR

9.4.8.2.1 POST-SURGERY & INTENSIVE HEALING TREATMENTS

9.4.8.2.2 DNA-BASED WOUND HEALING CREAMS

9.4.8.2.3 RNA-INFUSED SCAR-REPAIR SERUMS

9.4.8.2.4 SKIN BARRIER RECOVERY FORMULATIONS

9.4.8.2.5 CELLULAR RENEWAL TREATMENTS

9.4.8.2.5.1 DNA-STIMULATING SKIN RENEWAL SERUMS

9.4.8.2.5.2 RNA-BASED ENZYMATIC SKIN REPAIR MASKS

9.4.8.2.6 DNA DAMAGE REPAIR

9.4.8.2.6.1 UV-INDUCED DNA DAMAGE REVERSAL CREAMS

9.4.8.2.6.2 EPIGENETIC REPAIR SERUMS

9.4.8.2.6.3 OTHERS

9.4.8.3 UV PROTECTION & SUN DAMAGE REPAIR

9.4.8.3.1 DNA-BASED SUNSCREENS

9.4.8.3.1.1 BROAD-SPECTRUM UVA/UVB PROTECTION

9.4.8.3.1.2 PHOTOAGING DEFENSE FORMULAS

9.4.8.3.2 AFTER-SUN DNA REPAIR TREATMENTS

9.4.8.3.2.1 DNA-INFUSED POST-SUN EXPOSURE MASKS

9.4.8.3.2.2 RNA-BASED SUNBURN RECOVERY GELS

9.4.8.3.3 BLUE LIGHT & POLLUTION PROTECTION

9.4.8.3.3.1 DNA-POWERED DIGITAL DEFENSE CREAMS

9.4.8.3.3.2 RNA-BASED ENVIRONMENTAL SHIELD SERUMS

9.4.8.4 ACNE & SCAR TREATMENT

9.4.8.4.1 DNA-BASED ACNE CONTROL SERUMS

9.4.8.4.1.1 ANTI-BACTERIAL NUCLEIC ACID SERUMS

9.4.8.4.1.2 SEBUM-REGULATING RNA TREATMENTS

9.4.8.4.2 RNA-POWERED SCAR FADING CREAMS

9.4.8.4.2.1 POST-ACNE MARK CORRECTORS

9.4.8.4.2.2 EPIGENETIC TISSUE REGENERATION SERUMS

9.4.8.4.3 HORMONAL ACNE TREATMENTS

9.4.8.4.3.1 DNA-BASED HORMONAL BALANCING SKINCARE

9.4.8.4.3.2 RNA-INFUSED ANTI-INFLAMMATORY GELS

9.4.8.4.4 OIL-CONTROL & PORE REDUCTION

9.4.8.4.4.1 DNA-POWERED OIL-BALANCING CREAMS

9.4.8.4.4.2 RNA-BASED PORE-TIGHTENING TONERS

9.4.8.5 HYPERPIGMENTATION & DARK SPOT TREATMENT

9.4.8.5.1 DARK SPOT CORRECTORS

9.4.8.5.1.1 DNA-BASED SPOT FADING TREATMENTS

9.4.8.5.1.2 RNA-POWERED DISCOLORATION REDUCERS

9.4.8.5.2 UNEVEN SKIN TONE CORRECTION

9.4.8.5.2.1 DNA-BASED SKIN BRIGHTENING MASKS

9.4.8.5.2.2 GENE-TARGETED EVEN SKIN TONE SOLUTIONS

9.4.8.5.3 MELANIN-INHIBITING SERUMS

9.4.8.5.3.1 DNA-BASED TYROSINASE INHIBITORS

9.4.8.5.3.2 RNA-POWERED BRIGHTENING SERUMS

9.4.8.5.4 POST-INFLAMMATORY HYPERPIGMENTATION (PIH) TREATMENTS

9.4.8.5.4.1 NUCLEIC ACID-INFUSED ACNE MARK CORRECTORS

9.4.8.5.4.2 RNA-BASED REDNESS-REDUCING CREAMS

9.4.8.6 ANTI-AGING & WRINKLE REDUCTION

9.4.8.6.1 COLLAGEN-BOOSTING FORMULATIONS

9.4.8.6.1.1 DNA-INFUSED COLLAGEN SERUMS

9.4.8.6.1.2 RNA-BASED PEPTIDE BOOSTERS

9.4.8.6.1.3 GENE-STIMULATING COLLAGEN MASKS

9.4.8.6.1.4 OTHERS

9.4.8.6.2 SKIN FIRMING & ELASTICITY IMPROVEMENT

9.4.8.6.2.1 DNA-BASED SKIN TIGHTENING SERUMS

9.4.8.6.2.2 RNA-POWERED ELASTICITY-ENHANCING CREAMS

9.4.8.6.2.3 NUCLEIC ACID-INFUSED FACIAL LIFTING MASKS

9.4.8.6.2.4 OTHERS

9.4.8.6.3 FINE LINE TREATMENT

9.4.8.6.3.1 FOREHEAD LINE CORRECTORS

9.4.8.6.3.2 CROW’S FEET REDUCTION CREAMS

9.4.8.6.3.3 UNDER-EYE WRINKLE SERUMS

9.4.8.6.3.4 NASOLABIAL FOLD TREATMENT

9.4.8.6.3.5 OTHERS

9.4.8.6.4 DEEP WRINKLE REPAIR

9.4.8.6.4.1 DNA-BASED RETINOL ALTERNATIVES

9.4.8.6.4.2 EPIGENETIC WRINKLE-REDUCING SERUMS

9.4.8.6.4.3 OTHERS

9.4.8.7 SENSITIVE SKIN CARE & INFLAMMATION REDUCTION

9.4.8.7.1 SOOTHING & ANTI-REDNESS FORMULATIONS

9.4.8.7.1.1 RNA-BASED ROSACEA TREATMENTS

9.4.8.7.1.2 DNA-INFUSED CALMING MASKS

9.4.8.7.2 HYPOALLERGENIC DNA-BASED SKINCARE

9.4.8.7.2.1 SENSITIVE SKIN RNA CREAMS

9.4.8.7.2.2 FRAGRANCE-FREE DNA SERUMS

9.4.8.7.3 ANTI-INFLAMMATORY NUCLEIC ACID TREATMENTS

9.4.8.7.3.1 DNA-POWERED CYTOKINE-REDUCING SERUMS

9.4.8.7.3.2 RNA-BASED IRRITATION-REDUCING GELS

9.5 NUCLEIC ACID SPORTS FOOD ADDITIVES

9.5.1 SPORTS SUPPLEMENTS

9.5.1.1 POWDER

9.5.1.2 CAPSULES

9.5.1.3 OTHERS

9.5.2 SPORTS FOOD

10 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SOURCE

10.1 OVERVIEW

10.2 NATURAL NUCLEIC ACIDS

10.2.1 PLANT-BASED

10.2.2 MARINE-DERIVED

10.2.3 OTHERS

10.3 SYNTHETIC NUCLEIC ACIDS

11 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY END USER

11.1 OVERVIEW

11.2 INDIVIDUAL CONSUMERS/ HOME HEALTHCARE

11.2.1 WOMEN

11.2.2 MEN

11.2.3 UNISEX

11.3 PROFESSIONAL/FACILITY USE

11.3.1 DERMATOLOGY CLINICS

11.3.2 BEAUTY SALONS & SPAS

11.3.3 SPECIALTY CLINICS

11.3.4 HOSPITAL

11.3.5 OTHERS

12 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DISTRIBUTION CHANNEL

12.1 OVERVIEW

12.2 DIRECT TENDER

12.3 RETAIL SALES

12.3.1 BY TYPE

12.3.1.1 STORE BASED

12.3.1.1.1 SUPERMARKETS/HYPERMARKETS

12.3.1.1.2 SPECIALTY BEAUTY STORES

12.3.1.1.3 PHARMACIES & DRUGSTORES

12.3.1.1.4 DERMATOLOGY CLINICS & MEDICAL SPAS

12.3.1.1.5 TRAVEL RETAIL

12.3.1.1.6 OTHERS

12.3.1.2 NON STORE BASED

12.3.1.2.1 E-COMMERCE/PHARMACY WEBSITES

12.3.1.2.2 COMPANY-OWNED WEBSITES

12.4 OTHERS

13 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION

13.1 NORTH AMERICA

13.1.1 U.S.

13.1.2 CANADA

13.1.3 MEXICO

14 NORTH AMERICA NUCLEIC ACID THERAPEUTICS MARKET, COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

15 COMPANY PROFILES

15.1 PFIZER INC.

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.2 BIOGEN

15.2.1 COMPANY SNAPSHOT

15.2.2 RECENT FINANCIALS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS/NEWS

15.3 ALNYLAM PHARMACEUTICALS, INC.

15.3.1 COMPANY SNAPSHOT

15.3.2 RECENT FINANCIALS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT NEWS

15.4 SAREPTA THERAPEUTICS, INC.

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENT

15.5 IONIS PHARMACEUTICALS, INC.

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PIPELINE PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENTS

15.6 ASTRAZENECA

15.6.1 COMPANY SNAPSHOT

15.6.2 RECENT FINANCIALS

15.6.3 PIPELINE PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENT

15.7 MODERNA, INC.

15.7.1 COMPANY SNAPSHOT

15.7.2 RECENT FINANCIALS

15.7.3 PIPELINE PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENT

15.8 NOVARTIS AG

15.8.1 COMPANY SNAPSHOT

15.8.2 REVENUE ANALYSIS

15.8.3 PRODUCT PORTFOLIO

15.8.4 RECENT DEVELOPMENTS

15.9 SPARK THERAPEUTICS, INC.

15.9.1 COMPANY SNAPSHOT

15.9.2 PIPELINE PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENT

15.1 ZHEJIANG HAICHANG BIOPHARMACEUTICAL TECHNOLOGY CO., LTD.

15.10.1 COMPANY SNAPSHOT

15.10.2 PIPELINE PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENT

16 NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES AND SKIN CARE MARKET: COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

17 COMPANY PROFILES

17.1 REMY LAURE

17.1.1 COMPANY SNAPSHOT

17.1.2 COMPANY SHARE ANALYSIS

17.1.3 PRODUCT PORTFOLIO

17.1.4 RECENT DEVELOPMENT

17.2 NEOVA

17.2.1 COMPANY SNAPSHOT

17.2.2 COMPANY SHARE ANALYSIS

17.2.3 PRODUCT PORTFOLIO

17.2.4 RECENT DEVELOPMENT

17.3 MOONGLOW

17.3.1 COMPANY SNAPSHOT

17.3.2 COMPANY SHARE ANALYSIS

17.3.3 PRODUCT PORTFOLIO

17.3.4 RECENT DEVELOPMENT

17.4 THE NAKED CHEMIST

17.4.1 COMPANY SNAPSHOT

17.4.2 COMPANY SHARE ANALYSIS

17.4.3 PRODUCT PORTFOLIO

17.4.4 RECENT DEVELOPMENT

17.5 SKINSHIFT

17.5.1 COMPANY SNAPSHOT

17.5.2 COMPANY SHARE ANALYSIS

17.5.3 PRODUCT PORTFOLIO

17.5.4 RECENT DEVELOPMENT

17.6 BIO JOUVANCE PARIS CONSUMER

17.6.1 COMPANY SNAPSHOT

17.6.2 PRODUCT PORTFOLIO

17.6.3 RECENT DEVELOPMENT

17.7 DNA SKIN INSTITUTE

17.7.1 COMPANY SNAPSHOT

17.7.2 PRODUCT PORTFOLIO

17.7.3 RECENT DEVELOPMENT

17.8 JULIETTE ARMAND

17.8.1 COMPANY SNAPSHOT

17.8.2 PRODUCT PORTFOLIO

17.8.3 RECENT DEVELOPMENT

17.9 KALICHEM S.R.L.

17.9.1 COMPANY SNAPSHOT

17.9.2 PRODUCT PORTFOLIO

17.9.3 RECENT DEVELOPMENT

17.1 NIPPON PAPER INDUSTRIES CO., LTD.

17.10.1 COMPANY SNAPSHOT

17.10.2 REVENUE ANALYSIS

17.10.3 PRODUCT PORTFOLIO

17.10.4 RECENT DEVELOPMENT

17.11 POSTQUAM

17.11.1 COMPANY SNAPSHOT

17.11.2 PRODUCT PORTFOLIO

17.11.3 RECENT DEVELOPMENT

17.12 SHOPATDNA.COM

17.12.1 COMPANY SNAPSHOT

17.12.2 PRODUCT PORTFOLIO

17.12.3 RECENT DEVELOPMENT

18 QUESTIONNAIRE

19 RELATED REPORTS

Lista de Tablas

TABLE 1 PRODUCTION CAPACITY FOR TOP MANUFACTURERS

TABLE 2 NORTH AMERICA CLINICAL TRIAL MARKET FOR NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET

TABLE 3 DISTRIBUTION OF PRODUCTS AND PROJECTS BY PHASE NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET

TABLE 4 DISTRIBUTION OF PROJECTS BY THERAPEUTIC AREA AND PHASE NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET

TABLE 5 OVERVIEW OF THE EPIDEMIOLOGICAL DATA FOR ALZHEIMER'S DISEASE (AD), PARKINSON'S DISEASE (PD), AMYOTROPHIC LATERAL SCLEROSIS (ALS), RHEUMATOID ARTHRITIS (RA), AND SYSTEMIC LUPUS ERYTHEMATOSUS (SLE),

TABLE 6 REGULATORY COVERAGE

TABLE 7 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PRODUCT, 2024-2032 (USD THOUSANDS)

TABLE 8 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 9 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY CATEGORY, 2024-2032 (USD THOUSAND)

TABLE 10 NORTH AMERICA ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 11 NORTH AMERICA ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 12 NORTH AMERICA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 13 NORTH AMERICA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 14 NORTH AMERICA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 15 NORTH AMERICA CPG OLIGONUCLEOTIDES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 16 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY STRUCTURE, 2024-2032 (USD THOUSAND)

TABLE 17 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUG TYPE, 2024-2032 (USD THOUSAND)

TABLE 18 NORTH AMERICA MARKETED/APPROVED DRUGS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 19 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 20 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY ROUTE OF ADMINISTRATION, 2024-2032 (USD THOUSAND)

TABLE 21 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 22 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 23 NORTH AMERICA DNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 24 NORTH AMERICA DNA REPAIR SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 25 NORTH AMERICA DNA-INFUSED MOISTURIZERS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 26 NORTH AMERICA DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 27 NORTH AMERICA DNA-BASED FACE MASKS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 28 NORTH AMERICA DNA-INFUSED EYE CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 29 NORTH AMERICA RNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 30 NORTH AMERICA RNA-INFUSED CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 31 NORTH AMERICA RNA-BASED ANTI-AGING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 32 NORTH AMERICA GENE THERAPY-INFUSED SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 33 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SKIN TYPE, 2024-2032 (USD THOUSAND)

TABLE 34 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING, 2024-2032 (USD THOUSAND)

TABLE 35 NORTH AMERICA BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 36 NORTH AMERICA TUBES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 37 NORTH AMERICA DROPPER BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 38 NORTH AMERICA JARS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 39 NORTH AMERICA AMPOULES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 40 NORTH AMERICA SACHETS AND POUCHES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 41 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING SIZE, 2024-2032 (USD THOUSAND)

TABLE 42 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PRICE RANGE, 2024-2032 (USD THOUSAND)

TABLE 43 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 44 NORTH AMERICA MOISTURIZATION & HYDRATION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 45 NORTH AMERICA DEEP HYDRATION WITH NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 46 NORTH AMERICA LONG-LASTING HYDRATION SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 47 NORTH AMERICA SKIN BARRIER STRENGTHENING IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 48 NORTH AMERICA SKIN REGENERATION & REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 49 NORTH AMERICA POST-SURGERY & INTENSIVE HEALING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 50 NORTH AMERICA CELLULAR RENEWAL TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 51 NORTH AMERICA DNA DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 52 NORTH AMERICA UV PROTECTION & SUN DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 53 NORTH AMERICA DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 54 NORTH AMERICA AFTER-SUN DNA REPAIR TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 55 NORTH AMERICA BLUE LIGHT & POLLUTION PROTECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 56 NORTH AMERICA ACNE & SCAR TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 57 NORTH AMERICA DNA-BASED ACNE CONTROL SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 58 NORTH AMERICA RNA-POWERED SCAR FADING CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 59 NORTH AMERICA HORMONAL ACNE TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 60 NORTH AMERICA OIL-CONTROL & PORE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 61 NORTH AMERICA HYPERPIGMENTATION & DARK SPOT TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 62 NORTH AMERICA DARK SPOT CORRECTORS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 63 NORTH AMERICA UNEVEN SKIN TONE CORRECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 64 NORTH AMERICA MELANIN-INHIBITING SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 65 NORTH AMERICA POST-INFLAMMATORY HYPERPIGMENTATION (PIH) TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 66 NORTH AMERICA ANTI-AGING & WRINKLE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 67 NORTH AMERICA COLLAGEN-BOOSTING FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 68 NORTH AMERICA SKIN FIRMING & ELASTICITY IMPROVEMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 69 NORTH AMERICA FINE LINE TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 70 NORTH AMERICA DEEP WRINKLE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 71 NORTH AMERICA SENSITIVE SKIN CARE & INFLAMMATION REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 72 NORTH AMERICA SOOTHING & ANTI-REDNESS FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 73 NORTH AMERICA HYPOALLERGENIC DNA-BASED SKINCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 74 NORTH AMERICA ANTI-INFLAMMATORY NUCLEIC ACID TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 75 NORTH AMERICA NUCLEIC ACID SPORTS FOOD ADDITIVES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 76 NORTH AMERICA NUCLEIC ACID SPORTS FOOD ADDITIVES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 77 NORTH AMERICA SPORTS SUPPLEMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 78 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SOURCE, 2024-2032 (USD THOUSAND)

TABLE 79 NORTH AMERICA NATURAL NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 80 NORTH AMERICA NATURAL NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 81 NORTH AMERICA SYNTHETIC NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 82 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY END USER, 2024-2032 (USD THOUSAND)

TABLE 83 NORTH AMERICA INDIVIDUAL CONSUMERS/ HOME HEALTHCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 84 NORTH AMERICA INDIVIDUAL CONSUMERS/ HOME HEALTHCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 85 NORTH AMERICA PROFESSIONAL/FACILITY USE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 86 NORTH AMERICA PROFESSIONAL/FACILITY USE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 87 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DISTRIBUTION CHANNEL, 2024-2032 (USD THOUSAND)

TABLE 88 NORTH AMERICA DIRECT TENDER IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 89 NORTH AMERICA RETAIL SALES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 90 NORTH AMERICA RETAIL SALES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 91 NORTH AMERICA STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 92 NORTH AMERICA NON STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 93 NORTH AMERICA OTHERS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 94 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY COUNTRY, 2024-2032 (USD THOUSAND)

TABLE 95 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PRODUCT, 2024-2032 (USD THOUSAND)

TABLE 96 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY COUNTRY, 2024-2032 (USD THOUSAND)

TABLE 97 NORTH AMERICA NUCLEIC ACID SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY COUNTRY, 2024-2032 (USD THOUSAND)

TABLE 98 NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY COUNTRY, 2024-2032 (USD THOUSAND)

TABLE 99 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY CATEGORY, 2024-2032 (USD THOUSAND)

TABLE 100 NORTH AMERICA ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 101 NORTH AMERICA ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 102 NORTH AMERICA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 103 NORTH AMERICA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 104 NORTH AMERICA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 105 NORTH AMERICA CPG OLIGONUCLEOTIDES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 106 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY STRUCTURE, 2024-2032 (USD THOUSAND)

TABLE 107 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUG TYPE, 2024-2032 (USD THOUSAND)

TABLE 108 NORTH AMERICA MARKETED/APPROVED DRUGS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 109 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 110 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY ROUTE OF ADMINISTRATION, 2024-2032 (USD THOUSAND)

TABLE 111 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 112 NORTH AMERICA DNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 113 NORTH AMERICA DNA REPAIR SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 114 NORTH AMERICA DNA-INFUSED MOISTURIZERS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 115 NORTH AMERICA DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 116 NORTH AMERICA DNA-BASED FACE MASKS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 117 NORTH AMERICA DNA-INFUSED EYE CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 118 NORTH AMERICA RNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 119 NORTH AMERICA RNA-INFUSED CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 120 NORTH AMERICA RNA-BASED ANTI-AGING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 121 NORTH AMERICA GENE THERAPY-INFUSED SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 122 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SKIN TYPE, 2024-2032 (USD THOUSAND)

TABLE 123 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING, 2024-2032 (USD THOUSAND)

TABLE 124 NORTH AMERICA BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 125 NORTH AMERICA TUBES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 126 NORTH AMERICA DROPPER BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 127 NORTH AMERICA JARS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 128 NORTH AMERICA AMPOULES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 129 NORTH AMERICA SACHETS AND POUCHES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 130 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING SIZE, 2024-2032 (USD THOUSAND)

TABLE 131 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PRICE RANGE, 2024-2032 (USD THOUSAND)

TABLE 132 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 133 NORTH AMERICA MOISTURIZATION & HYDRATION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 134 NORTH AMERICA DEEP HYDRATION WITH NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 135 NORTH AMERICA LONG-LASTING HYDRATION SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 136 NORTH AMERICA SKIN BARRIER STRENGTHENING IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 137 NORTH AMERICA SKIN REGENERATION & REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 138 NORTH AMERICA POST-SURGERY & INTENSIVE HEALING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 139 NORTH AMERICA CELLULAR RENEWAL TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 140 NORTH AMERICA DNA DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 141 NORTH AMERICA UV PROTECTION & SUN DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 142 NORTH AMERICA DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 143 NORTH AMERICA AFTER-SUN DNA REPAIR TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 144 NORTH AMERICA BLUE LIGHT & POLLUTION PROTECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 145 NORTH AMERICA ACNE & SCAR TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 146 NORTH AMERICA DNA-BASED ACNE CONTROL SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 147 NORTH AMERICA RNA-POWERED SCAR FADING CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 148 NORTH AMERICA HORMONAL ACNE TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 149 NORTH AMERICA OIL-CONTROL & PORE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 150 NORTH AMERICA HYPERPIGMENTATION & DARK SPOT TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 151 NORTH AMERICA DARK SPOT CORRECTORS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 152 NORTH AMERICA UNEVEN SKIN TONE CORRECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 153 NORTH AMERICA MELANIN-INHIBITING SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 154 NORTH AMERICA POST-INFLAMMATORY HYPERPIGMENTATION (PIH) TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 155 NORTH AMERICA ANTI-AGING & WRINKLE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 156 NORTH AMERICA COLLAGEN-BOOSTING FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 157 NORTH AMERICA SKIN FIRMING & ELASTICITY IMPROVEMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 158 NORTH AMERICA FINE LINE TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 159 NORTH AMERICA DEEP WRINKLE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 160 NORTH AMERICA SENSITIVE SKIN CARE & INFLAMMATION REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 161 NORTH AMERICA SOOTHING & ANTI-REDNESS FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 162 NORTH AMERICA HYPOALLERGENIC DNA-BASED SKINCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 163 NORTH AMERICA ANTI-INFLAMMATORY NUCLEIC ACID TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 164 NORTH AMERICA NUCLEIC ACID SPORTS FOOD ADDITIVES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 165 NORTH AMERICA SPORTS SUPPLEMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 166 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SOURCE, 2024-2032 (USD THOUSAND)

TABLE 167 NORTH AMERICA NATURAL NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 168 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY END USER, 2024-2032 (USD THOUSAND)

TABLE 169 NORTH AMERICA INDIVIDUAL CONSUMERS/ HOME HEALTHCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 170 NORTH AMERICA PROFESSIONAL/FACILITY USE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 171 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DISTRIBUTION CHANNEL, 2024-2032 (USD THOUSAND)

TABLE 172 NORTH AMERICA RETAIL SALES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 173 NORTH AMERICA STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 174 NORTH AMERICA NON STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 175 U.S. NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY CATEGORY, 2024-2032 (USD THOUSAND)

TABLE 176 U.S. ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 177 U.S. ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 178 U.S. RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 179 U.S. RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 180 U.S. RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 181 U.S. CPG OLIGONUCLEOTIDES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 182 U.S. NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY STRUCTURE, 2024-2032 (USD THOUSAND)

TABLE 183 U.S. NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUG TYPE, 2024-2032 (USD THOUSAND)

TABLE 184 U.S. MARKETED/APPROVED DRUGS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 185 U.S. NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 186 U.S. NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY ROUTE OF ADMINISTRATION, 2024-2032 (USD THOUSAND)

TABLE 187 U.S. NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 188 U.S. DNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 189 U.S. DNA REPAIR SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 190 U.S. DNA-INFUSED MOISTURIZERS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 191 U.S. DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 192 U.S. DNA-BASED FACE MASKS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 193 U.S. DNA-INFUSED EYE CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 194 U.S. RNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 195 U.S. RNA-INFUSED CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 196 U.S. RNA-BASED ANTI-AGING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 197 U.S. GENE THERAPY-INFUSED SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 198 U.S. NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SKIN TYPE, 2024-2032 (USD THOUSAND)

TABLE 199 U.S. NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING, 2024-2032 (USD THOUSAND)

TABLE 200 U.S. BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 201 U.S. TUBES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 202 U.S. DROPPER BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 203 U.S. JARS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 204 U.S. AMPOULES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 205 U.S. SACHETS AND POUCHES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 206 U.S. NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING SIZE, 2024-2032 (USD THOUSAND)

TABLE 207 U.S. NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PRICE RANGE, 2024-2032 (USD THOUSAND)

TABLE 208 U.S. NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 209 U.S. MOISTURIZATION & HYDRATION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 210 U.S. DEEP HYDRATION WITH NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 211 U.S. LONG-LASTING HYDRATION SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 212 U.S. SKIN BARRIER STRENGTHENING IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 213 U.S. SKIN REGENERATION & REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 214 U.S. POST-SURGERY & INTENSIVE HEALING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 215 U.S. CELLULAR RENEWAL TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 216 U.S. DNA DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 217 U.S. UV PROTECTION & SUN DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 218 U.S. DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 219 U.S. AFTER-SUN DNA REPAIR TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 220 U.S. BLUE LIGHT & POLLUTION PROTECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 221 U.S. ACNE & SCAR TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 222 U.S. DNA-BASED ACNE CONTROL SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 223 U.S. RNA-POWERED SCAR FADING CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 224 U.S. HORMONAL ACNE TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 225 U.S. OIL-CONTROL & PORE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 226 U.S. HYPERPIGMENTATION & DARK SPOT TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 227 U.S. DARK SPOT CORRECTORS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 228 U.S. UNEVEN SKIN TONE CORRECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 229 U.S. MELANIN-INHIBITING SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 230 U.S. POST-INFLAMMATORY HYPERPIGMENTATION (PIH) TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 231 U.S. ANTI-AGING & WRINKLE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 232 U.S. COLLAGEN-BOOSTING FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 233 U.S. SKIN FIRMING & ELASTICITY IMPROVEMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 234 U.S. FINE LINE TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 235 U.S. DEEP WRINKLE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 236 U.S. SENSITIVE SKIN CARE & INFLAMMATION REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 237 U.S. SOOTHING & ANTI-REDNESS FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 238 U.S. HYPOALLERGENIC DNA-BASED SKINCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 239 U.S. ANTI-INFLAMMATORY NUCLEIC ACID TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 240 U.S. NUCLEIC ACID SPORTS FOOD ADDITIVES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 241 U.S. SPORTS SUPPLEMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 242 U.S. NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SOURCE, 2024-2032 (USD THOUSAND)

TABLE 243 U.S. NATURAL NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 244 U.S. NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY END USER, 2024-2032 (USD THOUSAND)

TABLE 245 U.S. INDIVIDUAL CONSUMERS/ HOME HEALTHCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 246 U.S. PROFESSIONAL/FACILITY USE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 247 U.S. NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DISTRIBUTION CHANNEL, 2024-2032 (USD THOUSAND)

TABLE 248 U.S. RETAIL SALES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 249 U.S. STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 250 U.S. NON STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 251 CANADA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY CATEGORY, 2024-2032 (USD THOUSAND)

TABLE 252 CANADA ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 253 CANADA ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 254 CANADA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 255 CANADA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 256 CANADA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 257 CANADA CPG OLIGONUCLEOTIDES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 258 CANADA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY STRUCTURE, 2024-2032 (USD THOUSAND)

TABLE 259 CANADA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUG TYPE, 2024-2032 (USD THOUSAND)

TABLE 260 CANADA MARKETED/APPROVED DRUGS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 261 CANADA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 262 CANADA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY ROUTE OF ADMINISTRATION, 2024-2032 (USD THOUSAND)

TABLE 263 CANADA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 264 CANADA DNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 265 CANADA DNA REPAIR SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 266 CANADA DNA-INFUSED MOISTURIZERS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 267 CANADA DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 268 CANADA DNA-BASED FACE MASKS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 269 CANADA DNA-INFUSED EYE CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 270 CANADA RNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 271 CANADA RNA-INFUSED CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 272 CANADA RNA-BASED ANTI-AGING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 273 CANADA GENE THERAPY-INFUSED SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 274 CANADA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SKIN TYPE, 2024-2032 (USD THOUSAND)

TABLE 275 CANADA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING, 2024-2032 (USD THOUSAND)

TABLE 276 CANADA BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 277 CANADA TUBES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 278 CANADA DROPPER BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 279 CANADA JARS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 280 CANADA AMPOULES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 281 CANADA SACHETS AND POUCHES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 282 CANADA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING SIZE, 2024-2032 (USD THOUSAND)

TABLE 283 CANADA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PRICE RANGE, 2024-2032 (USD THOUSAND)

TABLE 284 CANADA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 285 CANADA MOISTURIZATION & HYDRATION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 286 CANADA DEEP HYDRATION WITH NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 287 CANADA LONG-LASTING HYDRATION SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 288 CANADA SKIN BARRIER STRENGTHENING IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 289 CANADA SKIN REGENERATION & REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 290 CANADA POST-SURGERY & INTENSIVE HEALING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 291 CANADA CELLULAR RENEWAL TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 292 CANADA DNA DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 293 CANADA UV PROTECTION & SUN DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 294 CANADA DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 295 CANADA AFTER-SUN DNA REPAIR TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 296 CANADA BLUE LIGHT & POLLUTION PROTECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 297 CANADA ACNE & SCAR TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 298 CANADA DNA-BASED ACNE CONTROL SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 299 CANADA RNA-POWERED SCAR FADING CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 300 CANADA HORMONAL ACNE TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 301 CANADA OIL-CONTROL & PORE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 302 CANADA HYPERPIGMENTATION & DARK SPOT TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 303 CANADA DARK SPOT CORRECTORS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 304 CANADA UNEVEN SKIN TONE CORRECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 305 CANADA MELANIN-INHIBITING SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 306 CANADA POST-INFLAMMATORY HYPERPIGMENTATION (PIH) TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 307 CANADA ANTI-AGING & WRINKLE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 308 CANADA COLLAGEN-BOOSTING FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 309 CANADA SKIN FIRMING & ELASTICITY IMPROVEMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 310 CANADA FINE LINE TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 311 CANADA DEEP WRINKLE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 312 CANADA SENSITIVE SKIN CARE & INFLAMMATION REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 313 CANADA SOOTHING & ANTI-REDNESS FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 314 CANADA HYPOALLERGENIC DNA-BASED SKINCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 315 CANADA ANTI-INFLAMMATORY NUCLEIC ACID TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 316 CANADA NUCLEIC ACID SPORTS FOOD ADDITIVES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 317 CANADA SPORTS SUPPLEMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 318 CANADA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SOURCE, 2024-2032 (USD THOUSAND)

TABLE 319 CANADA NATURAL NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 320 CANADA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY END USER, 2024-2032 (USD THOUSAND)

TABLE 321 CANADA INDIVIDUAL CONSUMERS/ HOME HEALTHCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 322 CANADA PROFESSIONAL/FACILITY USE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 323 CANADA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DISTRIBUTION CHANNEL, 2024-2032 (USD THOUSAND)

TABLE 324 CANADA RETAIL SALES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 325 CANADA STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 326 CANADA NON STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 327 MEXICO NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY CATEGORY, 2024-2032 (USD THOUSAND)

TABLE 328 MEXICO ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 329 MEXICO ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 330 MEXICO RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 331 MEXICO RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 332 MEXICO RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 333 MEXICO CPG OLIGONUCLEOTIDES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 334 MEXICO NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY STRUCTURE, 2024-2032 (USD THOUSAND)

TABLE 335 MEXICO NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUG TYPE, 2024-2032 (USD THOUSAND)

TABLE 336 MEXICO MARKETED/APPROVED DRUGS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 337 MEXICO NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 338 MEXICO NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY ROUTE OF ADMINISTRATION, 2024-2032 (USD THOUSAND)

TABLE 339 MEXICO NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 340 MEXICO DNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 341 MEXICO DNA REPAIR SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 342 MEXICO DNA-INFUSED MOISTURIZERS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 343 MEXICO DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 344 MEXICO DNA-BASED FACE MASKS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 345 MEXICO DNA-INFUSED EYE CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 346 MEXICO RNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 347 MEXICO RNA-INFUSED CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 348 MEXICO RNA-BASED ANTI-AGING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 349 MEXICO GENE THERAPY-INFUSED SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 350 MEXICO NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SKIN TYPE, 2024-2032 (USD THOUSAND)

TABLE 351 MEXICO NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING, 2024-2032 (USD THOUSAND)

TABLE 352 MEXICO BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 353 MEXICO TUBES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 354 MEXICO DROPPER BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 355 MEXICO JARS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 356 MEXICO AMPOULES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 357 MEXICO SACHETS AND POUCHES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 358 MEXICO NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING SIZE, 2024-2032 (USD THOUSAND)

TABLE 359 MEXICO NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PRICE RANGE, 2024-2032 (USD THOUSAND)

TABLE 360 MEXICO NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 361 MEXICO MOISTURIZATION & HYDRATION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 362 MEXICO DEEP HYDRATION WITH NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 363 MEXICO LONG-LASTING HYDRATION SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 364 MEXICO SKIN BARRIER STRENGTHENING IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 365 MEXICO SKIN REGENERATION & REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 366 MEXICO POST-SURGERY & INTENSIVE HEALING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 367 MEXICO CELLULAR RENEWAL TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 368 MEXICO DNA DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 369 MEXICO UV PROTECTION & SUN DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 370 MEXICO DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 371 MEXICO AFTER-SUN DNA REPAIR TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 372 MEXICO BLUE LIGHT & POLLUTION PROTECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 373 MEXICO ACNE & SCAR TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 374 MEXICO DNA-BASED ACNE CONTROL SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 375 MEXICO RNA-POWERED SCAR FADING CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 376 MEXICO HORMONAL ACNE TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 377 MEXICO OIL-CONTROL & PORE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 378 MEXICO HYPERPIGMENTATION & DARK SPOT TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 379 MEXICO DARK SPOT CORRECTORS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 380 MEXICO UNEVEN SKIN TONE CORRECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 381 MEXICO MELANIN-INHIBITING SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 382 MEXICO POST-INFLAMMATORY HYPERPIGMENTATION (PIH) TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 383 MEXICO ANTI-AGING & WRINKLE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 384 MEXICO COLLAGEN-BOOSTING FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 385 MEXICO SKIN FIRMING & ELASTICITY IMPROVEMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 386 MEXICO FINE LINE TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 387 MEXICO DEEP WRINKLE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 388 MEXICO SENSITIVE SKIN CARE & INFLAMMATION REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 389 MEXICO SOOTHING & ANTI-REDNESS FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 390 MEXICO HYPOALLERGENIC DNA-BASED SKINCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 391 MEXICO ANTI-INFLAMMATORY NUCLEIC ACID TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 392 MEXICO NUCLEIC ACID SPORTS FOOD ADDITIVES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 393 MEXICO SPORTS SUPPLEMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 394 MEXICO NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SOURCE, 2024-2032 (USD THOUSAND)

TABLE 395 MEXICO NATURAL NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 396 MEXICO NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY END USER, 2024-2032 (USD THOUSAND)

TABLE 397 MEXICO INDIVIDUAL CONSUMERS/ HOME HEALTHCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 398 MEXICO PROFESSIONAL/FACILITY USE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 399 MEXICO NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DISTRIBUTION CHANNEL, 2024-2032 (USD THOUSAND)

TABLE 400 MEXICO RETAIL SALES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 401 MEXICO STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 402 MEXICO NON STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

Lista de figuras

FIGURE 1 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET

FIGURE 2 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: MULTIVARIATE MODELLING

FIGURE 7 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA NUCLEIC ACID THERAPEUTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA SPORT FOOD ADDITIVES AND SKIN CARE MARKET: DBMR MARKET POSITION GRID

FIGURE 10 NORTH AMERICA NUCLEIC ACID THERAPEUTICS,

FIGURE 11 SPORT FOOD ADDITIVES AND SKIN CARE MARKET

FIGURE 12 NORTH AMERICA NUCLEIC ACID THERAPEUTICS MARKET: END USER COVERAGE GRID

FIGURE 13 NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES AND SKIN CARE MARKET: END USER COVERAGE GRID

FIGURE 14 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: SEGMENTATION

FIGURE 15 GROWING DEMAND FOR FUNCTIONAL FOODS, NUTRACEUTICALS, AND BIOACTIVE SKINCARE INGREDIENTS IS EXPECTED TO DRIVE THE NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET IN THE FORECAST PERIOD

FIGURE 16 THE NUCLEIC ACID THERAPEUTICS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET IN 2025 AND 2032

FIGURE 17 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: EXECUTIVE SUMMARY

FIGURE 18 STRATEGIC DECISIONS

FIGURE 19 PORTER’S FIVE FORCES

FIGURE 20 IMPORT EXPORT SCENARIO (USD THOUSAND)

FIGURE 21 NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES AND SKIN CARE MARKET, 2024-2032, AVERAGE SELLING PRICE (USD/KG)

FIGURE 22 PATENT ANALYSIS BY COUNTRY

FIGURE 23 PATENT ANALYSIS BY COMPANY

FIGURE 24 NUMBER OF PATENT BY YEAR

FIGURE 25 DROC ANALYSIS

FIGURE 26 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: BY PRODUCT, 2024

FIGURE 27 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: BY SOURCE, 2024

FIGURE 28 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: BY END USER, 2024

FIGURE 29 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 30 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: SNAPSHOT, 2024

FIGURE 31 NORTH AMERICA NUCLEIC ACID THERAPEUTICS MARKET: COMPANY SHARE 2024 (%)

FIGURE 32 NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES AND SKIN CARE MARKET: COMPANY SHARE, 2024 (%)

Ver información detallada

Metodología de investigación

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.

La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.

Personalización disponible

Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.

Preguntas frecuentes

¿Cuáles son los principales segmentos cubiertos en el informe Informe de análisis del tamaño, la participación y las tendencias del mercado?

El mercado se segmenta según Segmentación del mercado norteamericano de productos terapéuticos con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel, por producto (productos terapéuticos con ácidos nucleicos, productos para el cuidado de la piel con ácidos nucleicos y aditivos alimentarios deportivos con ácidos nucleicos), origen (ácidos nucleicos naturales y sintéticos), usuario final (consumidores individuales/atención médica domiciliaria y uso profesional/en instalaciones), canal de distribución (licitación directa, venta minorista y otros): tendencias del sector y pronóstico hasta 2032. .

¿Cuál es el tamaño actual del mercado de Informe de análisis del tamaño, la participación y las tendencias del mercado?

El tamaño del Informe de análisis del tamaño, la participación y las tendencias del mercado se valoró en 5.50 USD Billion USD en 2024.

¿Cuál es la tasa de crecimiento esperada del Informe de análisis del tamaño, la participación y las tendencias del mercado?

Se prevé que el Informe de análisis del tamaño, la participación y las tendencias del mercado crezca a una CAGR de 7.14% durante el período de pronóstico de 2025 a 2032.

¿Quiénes son los principales actores en el Informe de análisis del tamaño, la participación y las tendencias del mercado?

Los principales actores del mercado incluyen Pfizer Inc., Biogen, Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc.,AstraZeneca.

Informe de análisis del tamaño, la participación y las tendencias del mercado de terapias con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel en Norteamérica: panorama general del sector y pronóstico hasta 2032

Supera los desafíos arancelarios con una consultoría ágil de la cadena de suministro

North America Nucleic Acid Therapeutics Sport Food Additives And Skin Care Market

Tasa de crecimiento anual compuesta (CAGR) : 7.14 %

Tamaño del mercado de terapias con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel

Análisis del mercado de terapias con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel

Ámbito del mercado de la terapia con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel

Cuota de mercado de productos terapéuticos con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel

Últimos avances en el mercado de ácidos nucleicos terapéuticos, aditivos alimentarios deportivos y cuidado de la piel.

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

Tabla de contenido

Lista de Tablas

Lista de figuras

Metodología de investigación

Personalización disponible

Preguntas frecuentes

Informes

Perspectivas del mercado

Apoyo

Soluciones

Informe de análisis del tamaño, la participación y las tendencias del mercado de terapias con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel en Norteamérica: panorama general del sector y pronóstico hasta 2032

Supera los desafíos arancelarios con una consultoría ágil de la cadena de suministro

North America Nucleic Acid Therapeutics Sport Food Additives And Skin Care Market

Tasa de crecimiento anual compuesta (CAGR) : 7.14 %

Tamaño del mercado de terapias con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel

Análisis del mercado de terapias con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel

Ámbito del mercado de la terapia con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel

Cuota de mercado de productos terapéuticos con ácidos nucleicos, aditivos alimentarios deportivos y cuidado de la piel

Últimos avances en el mercado de ácidos nucleicos terapéuticos, aditivos alimentarios deportivos y cuidado de la piel.

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

Tabla de contenido

Lista de Tablas

Lista de figuras

Metodología de investigación

Personalización disponible

Preguntas frecuentes

Explorar páginas relacionadas